ConductScience.org, home

Paper974986

Ten-year results of the treatment of primary operable breast carcinoma: A summary of 304 patients evaluated by the TNM system.

Schottenfeld D and 3 others. Cancer, 1976. Cited by 121 papers, by iCite.

11 sourcespapers-2026-11-12-0.1.0

Download JSON
Cite this record

ConductScience Library. Ten-year results of the treatment of primary operable breast carcinoma: A summary of 304 patients evaluated by the TNM system. Papers, record 974986. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/974986

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Ten-year results of the treatment of primary operable breast carcinoma: A summary of 304 patients evaluated by the TNM system.
PubMed
Journal
Cancer
PubMed
Year
1976
PubMed
Publication types
Journal Article
PubMed
Citations, by iCite
121
iCite
Relative citation ratio, by iCite
5.79
iCite
Revised in PubMed
2019-06-19
PubMed

Authors4

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Schottenfeld DD
2Nash AGA G
3Robbins GFG F
4Beattie EJ JrE J

Source PubMed

Topics9

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
Breast NeoplasmsMajor topic
CarcinomaMajor topic
Evaluation Studies as Topic
Female
Humans
Lymphatic Metastasis
Middle Aged
Neoplasm Metastasis
Time Factors

Source PubMed

Cited by18

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 121 citations.

PMIDTitleJournalYearIn PapersSource
25,759,625Prognostic Factors in Operated Stage IIIC, Pathological N3a Breast Cancer Patients.Breast Care (Basel)2014https://conductscience.org/library/papers/25759625PubMed
20,931,014NEO adjuvant chemotherapy in breast cancer: What have we learned so far?Indian J Med Paediatr Oncol2010https://conductscience.org/library/papers/20931014PubMed
16,142,429Nerve-sparing axillary dissection using the da Vinci Surgical System.World J Surg2005https://conductscience.org/library/papers/16142429PubMed
9,712,568Staging of the axilla in breast cancer: accurate in vivo assessment using positron emission tomography with 2-(fluorine-18)-fluoro-2-deoxy-D-glucose.Ann Surg1998https://conductscience.org/library/papers/9712568PubMed
8,968,695A risk-benefit assessment of anthracycline antibiotics in antineoplastic therapy.Drug Saf1996https://conductscience.org/library/papers/8968695PubMed
7,865,951Conservation surgery for breast cancer: selection criteria and technical considerations.Surg Today1994https://conductscience.org/library/papers/7865951PubMed
7,556,307The use of technetium-99m sestamibi to indicate breast cancer invasiveness.Eur J Nucl Med1995https://conductscience.org/library/papers/7556307PubMed
7,496,835Improved survival in young women with breast cancer.Ann Surg Oncol1995https://conductscience.org/library/papers/7496835PubMed
7,177,763Major stimulus dimensions determining detection of simulated breast lesions.Percept Psychophys1982https://conductscience.org/library/papers/7177763PubMed
6,880,183Irradiation as an alternative to mastectomy for early breast cancer.West J Med1983https://conductscience.org/library/papers/6880183PubMed
6,696,528Breast carcinoma in women 35 years of age or younger.Ann Surg1984https://conductscience.org/library/papers/6696528PubMed
3,801,277A suggested follow-up time for breast cancer patients.Br J Cancer1986https://conductscience.org/library/papers/3801277PubMed
1,627,815Prognostic factors in node-positive operable breast cancer patients receiving adjuvant chemotherapy.Breast Cancer Res Treat1992https://conductscience.org/library/papers/1627815PubMed
1,319,699Current management of male breast cancer. A review of 104 cases.Ann Surg1992https://conductscience.org/library/papers/1319699PubMed
728,351Survival and recurrences five years after selective treatment for breast carcinoma.Br J Cancer1978https://conductscience.org/library/papers/728351PubMed
650,646Clinical study of recurrence rate and survival time of patients with carcinoma of the breast treated by biopsy excision without any other therapy.J R Soc Med1978https://conductscience.org/library/papers/650646PubMed
497,947Five-year survival of women with breast cancer in northern Alberta.Can Med Assoc J1979https://conductscience.org/library/papers/497947PubMed
208,472Male breast cancer: a clinicopathologic study of 97 cases.Ann Surg1978https://conductscience.org/library/papers/208472PubMed

Genes1

The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.

GeneNCBI Gene IDLinked byIn Genes
TENM110,178PubTator's text mininghttps://conductscience.org/library/genes/10178

Source NCBI Gene

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Grants
  • Trials
  • Comments and corrections
  • References
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/974986

GET https://conductscience.org/api/papers/v1/974986/authors